PlainRecalls
FDA Drug Critical Class I Terminated

Phenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57), Rx only, Major Pharmaceuticals Livonia, MI 48152

Reported: December 27, 2023 Initiated: October 23, 2023 #D-0153-2024

Product Description

Phenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57), Rx only, Major Pharmaceuticals Livonia, MI 48152

Reason for Recall

Failed Content Uniformity Specifications

Details

Units Affected
3718 saleable units
Distribution
Nationwide in the USA
Location
La Vergne, TN

Frequently Asked Questions

What product was recalled?
Phenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57), Rx only, Major Pharmaceuticals Livonia, MI 48152. Recalled by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories. Units affected: 3718 saleable units.
Why was this product recalled?
Failed Content Uniformity Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on December 27, 2023. Severity: Critical. Recall number: D-0153-2024.